Skip to main content
Clinical Trials/NCT04673331
NCT04673331
Completed
N/A

Comparison of Physical Activity, Exercise Capacity, Quality of Life, Cognitive Function and Coronavirus Phobia Levels of Adult Cystic Fibrosis Patients With Healthy Individuals With Telerehabilitation in the COVID-19 Pandemic

Hacettepe University1 site in 1 country50 target enrollmentJanuary 5, 2021
ConditionsCystic Fibrosis

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cystic Fibrosis
Sponsor
Hacettepe University
Enrollment
50
Locations
1
Primary Endpoint
Weekly Average Steps
Status
Completed
Last Updated
last year

Overview

Brief Summary

The purpose of this study was to evaluate physical activity, exercise capacity, quality of life, cognitive status level and coronavirus phobia level of adult cystic fibrosis patients and compare with the findings of healthy subjects with teleconference during COVID-19 pandemic.

Detailed Description

This study will be participated adult with cystic fibrosis and healthy individuals. Demographic information of individuals will be recorded in online video conference. Physical activity, exercise capacity and cognitive function levels will be measured during video conferencing.Then, the physical activity level, coronavirus phobia and quality of life of the participants will be evaluated subjectively with questionnaires through the Google forms.

Registry
clinicaltrials.gov
Start Date
January 5, 2021
End Date
August 5, 2021
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Aydan Aslı Aksel Uylar

Physical Therapist

Hacettepe University

Eligibility Criteria

Inclusion Criteria

  • Being over 18 years old Having the ability to access the internet through a device (computer or mobile device) that enables video conferencing Giving consent on a voluntary basis

Exclusion Criteria

  • Severe comorbidity that limits mobilization or physical activity(orthopedic, cardiac or neurological condition) Pregnancy

Outcomes

Primary Outcomes

Weekly Average Steps

Time Frame: 2 minutes

The number of steps in the last week was recorded and averaged using the pedometer applications from the participants own smartphones. \<5000 steps/day sedentary 5000-7499 steps/day low active 7500-9999 steps/day somewhat active ≥10 000 steps/day active \>12 500 steps/day highly active

Physical Activity Level-International Physical Activity Questionnaire

Time Frame: 8 minutes

Physical activity level will be evaluated International Physical Activity Questionnaire- Short Form (IPAQ-SF). IPAQ short version asks spended time during sitting, walking, moderate and vigorous physical activities. The score is obtained by multiplying the minutes, days and metabolic equivalent values. According to these scores, physical activity levels are classified as "inactive", "minimally active" and "very active".

Coronavirus Phobia-Coronavirus-19 Phobia Scale

Time Frame: 5 minutes

COVID-19 phobia will be evaluated with Coronavirus-19 Phobia Scale (C19P-S) and total score ranges from 20-100. Lower scores mean better outcome.

Exercise Capacity

Time Frame: 15 minutes

Exercise capacity will be evaluated with 1-minute sit to stand test and 3-minute step test. Maximum heart rate, minimum saturation, count of step are record during the 3 minute step test. Number of sit to stand for 1 minute is recorded end of the 1 minute sit to stand test.

Secondary Outcomes

  • Quality Of Life-Nottingham Health Profile(10 minutes)
  • Cognitive Function-Standardized Mini Mental State Examination(5 minutes)

Study Sites (1)

Loading locations...

Similar Trials